Project:EveryChild A Registry, Eligibility Screening, Biology and Outcome Study
This research trial studies the Project: Every Child for younger patients with cancer. Gathering health information over time from younger patients with cancer may help doctors find better methods of treatment and on-going care.
Age: up to 25 years
•Enrollment can occur at any time after disease presentation including at time of disease progression or recurrence; for patients who are to be enrolled on COG therapeutic studies, enrollment on APEC14B1 must occur prior to enrollment onto the therapeutic trial
•Patients with a known or suspected neoplasm that occurs in the pediatric, adolescent or young adult populations are eligible for enrollment
Brenda Wittman, M.D.
COG (Childrens Oncology Group)
- Alaska Research
- Providence Alaska Medical Center